C McAleer
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Peter J. O’DwyerBruce J. GiantonioCorey J. LangerG. R. HudesR F OzolsJohn LeightonP F EngstromRobert L. Comis
- Topics
- Cancer Treatment and Pharmacology (11 papers)Lung Cancer Treatments and Mutations (6 papers)Lung Cancer Research Studies (5 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
C McAleer
23 papers receiving 855 citations
Peers
Comparison fields: 5 of 71
- Oncology 535
- Pulmonary and Respiratory Medicine 474
- Molecular Biology 225
- Cancer Research 151
- Radiology, Nuclear Medicine and Imaging 83
Countries citing papers authored by C McAleer
This map shows the geographic impact of C McAleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C McAleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C McAleer more than expected).
Fields of papers citing papers by C McAleer
This network shows the impact of papers produced by C McAleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C McAleer. The network helps show where C McAleer may publish in the future.
Co-authorship network of co-authors of C McAleer
This figure shows the co-authorship network connecting the top 25 collaborators of C McAleer. A scholar is included among the top collaborators of C McAleer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C McAleer. C McAleer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 41 | |
| 3 | 2 | |
| 4 | 29 | |
| 5 | 8 | |
| 6 | Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies. | 36 |
| 7 | 71 | |
| 8 | 206 | |
| 9 | 3 | |
| 10 | 15 | |
| 11 | Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. | 8 |
| 12 | Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. | 6 |
| 13 | 252 | |
| 14 | 29 | |
| 15 | 10 | |
| 16 | Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. | 59 |
| 17 | Phase I study of paclitaxel and estramustine: preliminary activity in hormone-refractory prostate cancer. | 25 |
| 18 | Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. | 8 |
| 19 | 6 | |
| 20 | 21 |
About C McAleer
C McAleer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 23 papers that have together received 891 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (535 citations), Pulmonary and Respiratory Medicine (474 citations) and Cancer Research (151 citations). C McAleer has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Peter J. O’Dwyer, Bruce J. Giantonio, Corey J. Langer, G. R. Hudes, R F Ozols, John Leighton, P F Engstrom, Robert L. Comis, Samuel Litwin and Faith E. Nathan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.